Federal Contract Opportunities
Showing 1,801-1,850 of 2,697 opportunities
These are federal procurement opportunities from SAM.gov for businesses to provide goods and services to government agencies.
FD2020-22-00860
NSN: 1630-01-333-1843 NOUN: HEAT SHIELD, WHEEL, A P/N: 537-5
One-Step Open BAA, US Army Combat Capabilities Development Command (DEVCOM) Indo-Pacific Fundamental Research Collaboration Opportunities
The purpose of this BAA is to solicit fundamental (basic and applied) research collaboration of full proposals, as defined in National Security Decision Directive (NSDD) 189, National Policy on Transfer of Scientific, Technical and Engineering Information, 21 September 1985. On 5 Dec 2024, Amendment 0006 was issued to remove the Award Ceiling.
One-Step Open BAA, US Army Combat Capabilities Development Command (DEVCOM) Indo-Pacific Fundamental Research Collaboration Opportunities
The purpose of this BAA is to solicit fundamental (basic and applied) research collaboration of full proposals, as defined in National Security Decision Directive (NSDD) 189, National Policy on Transfer of Scientific, Technical and Engineering Information, 21 September 1985.
One-Step Open BAA, US Army Combat Capabilities Development Command (DEVCOM) Indo-Pacific Fundamental Research Collaboration Opportunities
The purpose of this BAA is to solicit fundamental (basic and applied) research collaboration of full proposals, as defined in National Security Decision Directive (NSDD) 189, National Policy on Transfer of Scientific, Technical and Engineering Information, 21 September 1985.
One-Step Open BAA, US Army Combat Capabilities Development Command (DEVCOM) Indo-Pacific Fundamental Research Collaboration Opportunities
The purpose of this BAA is to solicit fundamental (basic and applied) research collaboration of full proposals, as defined in National Security Decision Directive (NSDD) 189, National Policy on Transfer of Scientific, Technical and Engineering Information, 21 September 1985.
One-Step Open BAA, US Army Combat Capabilities Development Command (DEVCOM) Indo-Pacific Fundamental Research Collaboration Opportunities
The purpose of this BAA is to solicit fundamental (basic and applied) research collaboration of full proposals, as defined in National Security Decision Directive (NSDD) 189, National Policy on Transfer of Scientific, Technical and Engineering Information, 21 September 1985.
One-Step Open BAA, US Army Combat Capabilities Development Command (DEVCOM) Indo-Pacific Fundamental Research Collaboration Opportunities
The purpose of this BAA is to solicit fundamental (basic and applied) research collaboration of full proposals, as defined in National Security Decision Directive (NSDD) 189, National Policy on Transfer of Scientific, Technical and Engineering Information, 21 September 1985.
One-Step Open BAA, US Army Combat Capabilities Development Command (DEVCOM) Indo-Pacific Fundamental Research Collaboration Opportunities
The purpose of this BAA is to solicit fundamental (basic and applied) research collaboration of full proposals, as defined in National Security Decision Directive (NSDD) 189, National Policy on Transfer of Scientific, Technical and Engineering Information, 21 September 1985.
One-Step Open BAA, US Army Combat Capabilities Development Command (DEVCOM) Indo-Pacific Fundamental Research Collaboration Opportunities
The purpose of this BAA is to solicit fundamental (basic and applied) research collaboration of full proposals, as defined in National Security Decision Directive (NSDD) 189, National Policy on Transfer of Scientific, Technical and Engineering Information, 21 September 1985. On 20 May 2025, Amendment 0007 was issued to update Attachment 4: Cost Template Guide with current FY 25 Presidential Exchange Rates. On 5 Dec 2024, Amendment 0006 was issued to remove the Award Ceiling.
FD2020-22-00974
1450-01-540-6277AH TRUCK,GUIDED MISSILE
FD2020-22-01011-00
1620-01-252-4091LE DRAG BRACE,LANDING
FD2020-22-01047
NSN: 1620-01-252-04042 NOUN: PISTON, LANDING GEAR P/N: 2007602-103
FD2020-22-01124
1560-01-224-0803WF CELL,FUEL,AIRCRAFT
FD2020-22-01143
1680010854423WF ACTUATOR,ELECTRO-ME 313 IMAGES
FD2020-22-01122-00
1630-01-038-5126LE WHEEL,LANDING GEAR
FD2020-22-01032
4920015377747WF TEST SET, ELECTRONIC 3 IMAGES
FD2020-22-01144
1450-01-392-1822AH HANDLING UNIT,GUIDE
FD2020-23-00023
4935001065242AH FIXTURE, GUIDED MISSILE 441 IMAGES
FD2020-22-01153
NSN: 5306016428613LE NOUN: BOLT,MACHINE P/N: 201416427-01
FD2020-22-01026
1680-01-263-0648WF GRIP ASSEMBLY,CONTR
Structural Materials Open BAA
Air Force Research Laboratory, Materials & Manufacturing Directorate, Structural Materials Division, AFRL/RXC, is soliciting white papers and potentially technical and cost proposals under this announcement that support the needs of its Structural Materials and Applications mission. Structural Materials technologies that range from materials and scientific discovery through technology development and transition are of interest. Descriptors of Materials and Manufacturing Directorate technology interests are presented in two contexts in the Statement of Objectives (BAA Attachment 1); that of structural materials science and engineering academic "competencies," and that of Air Force application area needs.
FD2020-23-50006
NSN: 1377-01-220-3746 AND 1377-01-167-6221 P/N: L325C2011 NOUN: INITIATOR,PROPELLAN
FD2020-22-01175
NSN: 1620011365173 NOUN: NOSE BX ASSY
Tanker Truck Fuel Pick-up
Amendment issued to answer venodr's questions.
DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA
The USAMRDC’s mission is to provide solutions to medical problems of importance to the American Service Member at home and abroad, as well as to the general public at large. The scope of this effort and the priorities attached to specific projects are influenced by changes in military and civilian medical science and technology (S&T), operational requirements, military threat assessments, and national defense strategies. Extramural research and development programs play a vital role in the fulfillment of the objectives established by the USAMRDC. General information on the USAMRDC can be obtained at https://mrdc.health.mil/. This BAA is intended to solicit extramural research and development ideas using the authority provided by 10 USC 4001. The BAA is issued under the provisions of the Competition in Contracting Act of 1984 (Public Law 98-369), as implemented in FAR 6.102(d)(2) and 35.016 and in Department of Defense Grant and Agreement Regulations (DoDGARs) 22.315. In accordance with FAR 35.016, projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed toward advancing the state-of-the-art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution. Research and development funded through this BAA are intended and expected to benefit and inform both military and civilian medical practice and knowledge. This BAA utilizes competitive procedures in accordance with 10 USC 2302(2)(B) for the selection for award of S&T proposals/applications. For the purposes of this BAA, S&T includes activities involving basic research, applied research, advanced technology development, and, under certain conditions, may include activities involving advanced component development and prototypes. The selection process is highly competitive, and the quantity of meaningful submissions (both pre-proposals/pre-applications and full proposals/applications) received typically exceeds the number of awards that available funding can support. This BAA provides a general description of USAMRDC’s research and development programs, including Research Areas of Interest, evaluation and selection criteria, pre-proposal/ pre-application and full proposal/application preparation instructions, and general administrative information. Specific submission information and additional administrative requirements can be found in the document titled, “General Submission Instructions,” which is available on Grants.gov along with this BAA. The FY23-FY27 USAMRDC BAA is continuously open for a 5-year period, from October 1, 2022 through September 30, 2027, at 11:59 p.m. Eastern Time. Submission of a pre-proposal/pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org/). Pre-proposals/pre-applications may be submitted at any time throughout the 5-year period. If the USAMRDC is interested in receiving a full proposal/application, the Principal Investigator will be sent an invitation to submit via eBRAP. A full proposal/application must be submitted through Grants.gov (http://www.grants.gov/). Invited full proposals/applications can be submitted under this FY23-FY27 BAA through September 30, 2027.
DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for ExtramuralMedical Research Department of Defense Dept. of the Army -- USAMRAA
The USAMRDC’s mission is to provide solutions to medical problems of importance to the American Service Member at home and abroad, as well as to the general public at large. The scope of this effort and the priorities attached to specific projects are influenced by changes in military and civilian medical science and technology (S&T), operational requirements, military threat assessments, and national defense strategies. Extramural research and development programs play a vital role in the fulfillment of the objectives established by the USAMRDC. General information on the USAMRDC can be obtained at https://mrdc.health.mil/. This BAA is intended to solicit extramural research and development ideas using the authority provided by 10 USC 4001. The BAA is issued under the provisions of the Competition in Contracting Act of 1984 (Public Law 98-369), as implemented in FAR 6.102(d)(2) and 35.016 and in Department of Defense Grant and Agreement Regulations (DoDGARs) 22.315. In accordance with FAR 35.016, projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed toward advancing the state-of-the-art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution. Research and development funded through this BAA are intended and expected to benefit and inform both military and civilian medical practice and knowledge. This BAA utilizes competitive procedures in accordance with 10 USC 2302(2)(B) for the selection for award of S&T proposals/applications. For the purposes of this BAA, S&T includes activities involving basic research, applied research, advanced technology development, and, under certain conditions, may include activities involving advanced component development and prototypes. The selection process is highly competitive, and the quantity of meaningful submissions (both pre-proposals/pre-applications and full proposals/applications) received typically exceeds the number of awards that available funding can support. This BAA provides a general description of USAMRDC’s research and development programs, including Research Areas of Interest, evaluation and selection criteria, pre-proposal/ pre-application and full proposal/application preparation instructions, and general administrative information. Specific submission information and additional administrative requirements can be found in the document titled, “General Submission Instructions,” which is available on Grants.gov along with this BAA. The FY23-FY27 USAMRDC BAA is continuously open for a 5-year period, from October 1, 2022 through September 30, 2027, at 11:59 p.m. Eastern Time. Submission of a pre-proposal/pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org/). Pre-proposals/pre-applications may be submitted at any time throughout the 5-year period. If the USAMRDC is interested in receiving a full proposal/application, the Principal Investigator will be sent an invitation to submit via eBRAP. A full proposal/application must be submitted through Grants.gov (http://www.grants.gov/). Invited full proposals/applications can be submitted under this FY23-FY27 BAA through September 30, 2027.
F16_Radar_Antenna_Phase_Shift_Driver_Unit_NSN1270015616088_PN562R218H01
RQR 2025
F-16 Radar Antenna Phase Shift Driver Unit NSN: 1270-01-561-6088 PN: 562R218H01
RQR 2025
C1DA--NCO 17 AE Short Selection Database FY24 - FY27
36C25723R0049 A0002
C1DA--NCO 17 AE Short Selection Database FY24 - FY27
36C25723R0049 A0002
Q402--Q402- Atlanta VAMC Community Nursing Home Services
Presolicitation Notice Presolicitation Notice Page 3 of 3 Solicitation Description Presolicitation Notice Page 1 of 3 Solicitation Number: 36C24724R0073 The solicitation is issued on an unrestricted basis all businesses are invited to participate. The NAICS code is 623110, Nursing Care Facilities (Skilled Nursing Facilities) with a $34M size standard. The solicitation is issued as an open and continuous basis and will be available to vendors from the date of issuance of the solicitation and continuing for one year. During that period all interested parties are invited to submit a proposal for consideration. The solicitation is issued on June 18, 2024. This acquisition is to provide Community Nursing Home (CNH) services in the Atlanta VAMC catchment area. The following counties are included in this catchment area: Towns, Union, Gordon, Pickens, Dawson, Lumpkin, Floyd, Bartow, Cherokee, Forsyth, Hall, Banks, Polk, Paulding, Cobb, Gwinnett, Barrow, Jackson, Haralson, Carroll, Douglas, Fulton, Dekalb, Rockdale, Walton, Oconee, Clarke, Heard, Coweta, Troup, Meriwether, Pike, Upson, Lamar, Spaulding, Butts, Jasper, Newton, Morgan, Clayton, Fayette and Henry counties. The Contractor shall furnish all supplies and services, at the per diem rates for the Levels of Care specified.  Nursing home facilities in the CNH program shall ensure that care meets the health needs and promotes the maximum well-being of VA patients. Nursing home care will be furnished to ensure the total medical, nursing, and psychosocial needs of VA beneficiaries. All nursing home facilities in VA s CNH program must have current Center for Medicare and Medicaid Services (CMS) certification (Medicare and/or Medicaid) and a state nursing home license. VA often has a particular need for specialty care services in the CNH program. The VA requires CNHs to have bed capacity to ensure their ability to take referrals when requested. The CNH also must be able to accept VA referrals in a timely fashion (ideally within 24 hours of request). Provider visits will be available at the rate of one (1) visit per month. Laboratory, x-ray, and other special services will be available to VA patients as needed. In addition, the care provided will include room, meals, nursing care, and other services or supplies commensurate with the VA-authorized level of care, without extra charge. Duly authorized representatives of VA will provide quality oversight visits to veterans placed to assure continuity of care and to assist in the veterans transition back into the community, when applicable.  It is anticipated that single award Indefinite Delivery Indefinite Quantity (IDIQ) contracts will be awarded from this solicitation. The capacity of each IDIQ will be based on the estimated value for a Nursing Home in each specific county and will range from $750,000 to $3,000,000. The period of performance for each IDIQ will be based on the award date and will continue for 5 years. Any questions regarding this acquisition can be directed to Contract Specialist William Prenzler William.prenzler@va.gov and Contracting Officer Laurinda Millage Laurinda.millage@va.gov .
CHEERS MAA Open Period 2 - All Technical Areas, 10 U.S.C. 4023 - Procurement for Experimental Purposes (ARA)
Solicitation: FA238424S2335, "Open Period 2 - All Technical Areas" Solicitation Authority: 10 U.S.C 4023 - Procurement for Experimental Purposes Related Notice: Multiple Authority Announcement (MAA) FA238424S2233, "Continuinig Human Enabliing, Enhancing, Restoring and Sustaining (CHEERS)" List of Attachments: 1. "Open Period Solicitation 2" 2. "Attachment 1 - List of Provisions and Clauses" **Note: Refer to the related notice identified above for additional attachments referenced herein (e.g. CHEERS Industry Guide)
CHEERS MAA Open Period 1 - All Technical Areas, 10 U.S.C. 4001 Broad Agency Announcement (BAA)
Solicitation: FA238424S2334, "Open Period 1 - All Technical Areas" Solicitation Authority: 10 U.S.C 4001 - Federal Acquisition Regulation and its Supplements (FAR(S)) / FAR 35 Part 35.016 (Broad Agency Announcements (BAA)) Related Notice: Multiple Authority Announcement (MAA) FA238424S2233, "Continuinig Human Enabliing, Enhancing, Restoring and Sustaining (CHEERS)" List of Attachments: 1. "Open Period Solicitation 1" 2. "Attachment 1 - List of Provisions and Clauses" **Note: Refer to the related notice identified above for additional attachments referenced herein (e.g. CHEERS Industry Guide)
DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA
The USAMRDC’s mission is to provide solutions to medical problems of importance to the American Service Member at home and abroad, as well as to the general public at large. The scope of this effort and the priorities attached to specific projects are influenced by changes in military and civilian medical science and technology (S&T), operational requirements, military threat assessments, and national defense strategies. Extramural research and development programs play a vital role in the fulfillment of the objectives established by the USAMRDC. General information on the USAMRDC can be obtained at https://mrdc.health.mil/. This BAA is intended to solicit extramural research and development ideas using the authority provided by 10 USC 4001. The BAA is issued under the provisions of the Competition in Contracting Act of 1984 (Public Law 98-369), as implemented in FAR 6.102(d)(2) and 35.016 and in Department of Defense Grant and Agreement Regulations (DoDGARs) 22.315. In accordance with FAR 35.016, projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed toward advancing the state-of-the-art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution. Research and development funded through this BAA are intended and expected to benefit and inform both military and civilian medical practice and knowledge. This BAA utilizes competitive procedures in accordance with 10 USC 2302(2)(B) for the selection for award of S&T proposals/applications. For the purposes of this BAA, S&T includes activities involving basic research, applied research, advanced technology development, and, under certain conditions, may include activities involving advanced component development and prototypes. The selection process is highly competitive, and the quantity of meaningful submissions (both pre-proposals/pre-applications and full proposals/applications) received typically exceeds the number of awards that available funding can support. This BAA provides a general description of USAMRDC’s research and development programs, including Research Areas of Interest, evaluation and selection criteria, pre-proposal/ pre-application and full proposal/application preparation instructions, and general administrative information. Specific submission information and additional administrative requirements can be found in the document titled, “General Submission Instructions,” which is available on Grants.gov along with this BAA. The FY23-FY27 USAMRDC BAA is continuously open for a 5-year period, from October 1, 2022 through September 30, 2027, at 11:59 p.m. Eastern Time. Submission of a pre-proposal/pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org/). Pre-proposals/pre-applications may be submitted at any time throughout the 5-year period. If the USAMRDC is interested in receiving a full proposal/application, the Principal Investigator will be sent an invitation to submit via eBRAP. A full proposal/application must be submitted through Grants.gov (http://www.grants.gov/). Invited full proposals/applications can be submitted under this FY23-FY27 BAA through September 30, 2027.
DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA
The USAMRDC’s mission is to provide solutions to medical problems of importance to the American Service Member at home and abroad, as well as to the general public at large. The scope of this effort and the priorities attached to specific projects are influenced by changes in military and civilian medical science and technology (S&T), operational requirements, military threat assessments, and national defense strategies. Extramural research and development programs play a vital role in the fulfillment of the objectives established by the USAMRDC. General information on the USAMRDC can be obtained at https://mrdc.health.mil/. This BAA is intended to solicit extramural research and development ideas using the authority provided by 10 USC 4001. The BAA is issued under the provisions of the Competition in Contracting Act of 1984 (Public Law 98-369), as implemented in FAR 6.102(d)(2) and 35.016 and in Department of Defense Grant and Agreement Regulations (DoDGARs) 22.315. In accordance with FAR 35.016, projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed toward advancing the state-of-the-art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution. Research and development funded through this BAA are intended and expected to benefit and inform both military and civilian medical practice and knowledge. This BAA utilizes competitive procedures in accordance with 10 USC 2302(2)(B) for the selection for award of S&T proposals/applications. For the purposes of this BAA, S&T includes activities involving basic research, applied research, advanced technology development, and, under certain conditions, may include activities involving advanced component development and prototypes. The selection process is highly competitive, and the quantity of meaningful submissions (both pre-proposals/pre-applications and full proposals/applications) received typically exceeds the number of awards that available funding can support. This BAA provides a general description of USAMRDC’s research and development programs, including Research Areas of Interest, evaluation and selection criteria, pre-proposal/ pre-application and full proposal/application preparation instructions, and general administrative information. Specific submission information and additional administrative requirements can be found in the document titled, “General Submission Instructions,” which is available on Grants.gov along with this BAA. The FY23-FY27 USAMRDC BAA is continuously open for a 5-year period, from October 1, 2022 through September 30, 2027, at 11:59 p.m. Eastern Time. Submission of a pre-proposal/pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org/). Pre-proposals/pre-applications may be submitted at any time throughout the 5-year period. If the USAMRDC is interested in receiving a full proposal/application, the Principal Investigator will be sent an invitation to submit via eBRAP. A full proposal/application must be submitted through Grants.gov (http://www.grants.gov/). Invited full proposals/applications can be submitted under this FY23-FY27 BAA through September 30, 2027.
OUSD(R&E) Seeks Advanced Manufacturing, Prototypes and Materials (AMPAM)
The Office of the Undersecretary of Defense for Research and Engineering (OUSD(R&E)) Manufacturing Technology Program (ManTech) invites companies with new manufacturing processes and emerging technologies to submit Concept White Paper(s) and Quad Chart(s) with potential for integration into the Department of Defense’s (DoD) industrial base. OUSD(R&E)’s goal is to foster increased collaboration and partnership between Government and Industry to identify, develop, and mature new or improved manufacturing and repair processes and bridge the gap between discovery and implementation of new capabilities for the warfighter. Periodic calls for submissions will be issued under this announcement as Capability Focus Areas (CFA). Submissions will be reviewed by the Government for relevance and merit in addressing the CFA. Responses can be submitted in response to the BOTA and/or the periodic CFAs. Responses to the BOTA will be accepted until the closing date of the BOTA. Responses to CFAs will be due forty-five days after issuance to sam.gov. There is no limit to the number of submissions; however, those desiring to submit under multiple technical areas must submit separate white papers and/or presentations. Anticipated Award Types include: Non-funded Information Exchange Agreement (IEA) for the purposes of exchanging controlled and sensitive technical information up to a Top Secret (TS), Facility Clearance Level (FCL) and Special Access Programs (SAP); Other Transaction (OT) agreement; or FAR-based procurement contract. The BOTA will remain open for 3 years and any non-funded IEA resulting from it will expire 2 years from the date of execution, unless otherwise agreed to by the parties. *Reference BOTA number HQ003425BOTA1 in all correspondence. The issuing agency contact is for general BOTA questions. All technical questions should be addressed to the Technical Point of Contact.
OUSD(R&E) Seeks Advanced Manufacturing, Prototypes and Materials (AMPAM)
UPDATED 25 NOV 2024: BOTA description had conflicting timeframes that the announcement is open. It is revised to reflect 3 years. UPDATED 25 OCT 2024: Email address in sam.gov contact information was corrected. Please use whs.mc-alex.ad.mbx.rpab@mail.mil. The Office of the Undersecretary of Defense for Research and Engineering (OUSD(R&E)) Manufacturing Technology Program (ManTech) invites companies with new manufacturing processes and emerging technologies to submit Concept White Paper(s) and Quad Chart(s) with potential for integration into the Department of Defense’s (DoD) industrial base. OUSD(R&E)’s goal is to foster increased collaboration and partnership between Government and Industry to identify, develop, and mature new or improved manufacturing and repair processes and bridge the gap between discovery and implementation of new capabilities for the warfighter. Periodic calls for submissions will be issued under this announcement as Capability Focus Areas (CFA). Submissions will be reviewed by the Government for relevance and merit in addressing the CFA. Responses can be submitted in response to the BOTA and/or the periodic CFAs. Responses to the BOTA will be accepted until the closing date of the BOTA. Responses to CFAs will be due forty-five days after issuance to sam.gov. There is no limit to the number of submissions; however, those desiring to submit under multiple technical areas must submit separate white papers and/or presentations. Anticipated Award Types include: Non-funded Information Exchange Agreement (IEA) for the purposes of exchanging controlled and sensitive technical information up to a Top Secret (TS), Facility Clearance Level (FCL) and Special Access Programs (SAP); Other Transaction (OT) agreement; or FAR-based procurement contract. The BOTA will remain open for 3 years and any non-funded IEA resulting from it will expire 2 years from the date of execution, unless otherwise agreed to by the parties. *Reference BOTA number HQ003425BOTA1 in all correspondence. The issuing agency contact is for general BOTA questions. All technical questions should be addressed to the Technical Point of Contact.
FD2020-22-01040
2835-01-115-6111RP SHAFT,TURBINE,NONAI
FD2020-23-00026
2835-01-308-3769RP ENGINE,GAS TURBINE,
848_SCMG_MQR_17_Aug2020
848 SCMG MQR 17 Aug 2020
848_SCMG_MQR_17_Aug2020
848 SCMG MQR 17 Aug 2020
848_SCMG_MQR_17_Aug2020
848 SCMG MQR 17 Aug 2020
FD2020-23-00035
3010014622032AH CLUTCH ASSEMBLY 3 IMAGES
HC-144 & HC-27J Inverter Repair
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 and Part 13.5, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. Solicitation number 70Z03824QL0000077 is issued as a Request for Quote (RFQ). The applicable North American Industry Classification System Code is 488190. The small business size standard is $40M. The award will be in accordance with FAR 6.302-1. It is anticipated that an Indefinite Delivery Requirements contract consisting of a one-year base period and two one-year option periods shall be awarded as a result of this synopsis/solicitation. The total duration of this contract shall not exceed three (3) years. Offeror’s must submit prices for all three years in order to be considered for award. The Coast Guard does not own, nor can it provide specifications, plans, drawings or other technical data. The USCG intends to award to Avionics Instruments, LLC, 1414 Randolph Ave., Avenel, NJ 07001, the Original Equipment Manufacturer (OEM) of the parts that are being repaired. These parts are used on the HC-144 and HC-27J aircraft. ALL QUANTITIES ARE ESTIMATES. All responsible sources may submit a quote which shall be considered by the agency. See Attached Documents: Attachment 1: Terms and Conditions Attachment 2: Schedule of Services Attachment 3: Statement of Work (SOW) Attachment 4: Redacted J&A Attachment 5: Wage Determination No. 2015-4193 Closing date and time for receipt of offers is 10/17/2024 at 4:00 PM EST. All questions and proposals submissions must be sent to Stephanie.O.Reams@uscg.mil. Telephone questions will not be accepted. Email proposals are requested and accepted. *Please indicate 70Z03824QL0000077 in the attention line. NOTICE FOR FILING AGENCY PROTESTS United States Coast Guard Ombudsman Program It is the policy of the United States Coast Guard (USCG) to issue solicitations and make contract awards in a fair and timely manner. The Ombudsman Program for Agency Protests (OPAP) was established to investigate agency protest issues and resolve them without expensive and time- consuming litigation. OPAP is an independent reviewing authority that is empowered to grant a prevailing protester essentially the same relief as the Government Accountability Office (GAO). Interested parties are encouraged to seek resolution of their concerns within the USCG as an Alternative Dispute Resolution (ADR) forum rather than filing a protest with the GAO or some external forum. Interested parties may seek resolution of their concerns informally or opt to file a formal agency protest with the Contracting Officer or Ombudsman. Informal Forum with the Ombudsman. Interested parties who believe a specific USCG procurement is unfair or otherwise defective should first direct their concerns to the applicable Contracting Officer. If the Contracting Officer is unable to satisfy their concerns, interested parties are encouraged to contact the U.S. Coast Guard Ombudsman for Agency Protests and CC the Contracting Officer. Under this informal process the agency is not required to suspend contract award performance. Use of an informal forum does not suspend any time requirement for filing a protest with the agency or other forum. In order to ensure a timely response, interested parties should provide the following information to the Ombudsman at OPAP@uscg.mil and the Contracting Officer: solicitation/contract number, contracting office, Contracting Officer’s name, solicitation closing date (if applicable), and their concerns. Formal Agency Protest with the Ombudsman. Prior to submitting a formal agency protest, protesters must first use their best efforts to resolve their concerns with the Contracting Officer through open and frank discussions. If the protester’s concerns are unresolved, an Independent Review is available by the Ombudsman. The protester may file a formal agency protest to either the Contracting Officer or as an alternative to that, the Ombudsman under the OPAP program, and CC the Contracting Officer in all communications. Contract award or performance will be suspended during the protest period unless contract award or performance is justified, in writing, for urgent and compelling reasons or is determined in writing to be in the best interest of the government. The agency’s goal is to resolve protests in less than 35 calendar days from the date of filing. Protests shall include the information set forth in FAR 33.103(d)(2). If the protester fails to submit the required information, resolution of the protest may be delayed or the protest may be dismissed. To be timely protests must be filed within the period specified in FAR 33.103(e). Formal protests filed under the OPAP program should be emailed to OPAP@uscg.mil and the Contracting Officer. Election of Forum. After an interested party protests a Coast Guard procurement to the Contracting Officer or the Ombudsman, and while the protest is pending, the protester agrees not to file a protest with the GAO or other external forum. If the protest is filed with an external forum, the agency protest will be dismissed.
FD2020-23-00034
5996014623656AH AMPLIFIER, ELECTRONIC 2 IMAGES
FD2020-22-01129
2835014595972YP ENGINE,GAS TURBINE 4 IMAGES
BARDA DRIVe EZ-BAA-22-100-SOL-00003
This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/.
BARDA DRIVe EZ-BAA-22-100-SOL-00003
This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/. _______ Amendment 001: This amendment to the EZBAA hereby opens the following research areas of interest ("AOI"). Please review the amendment for details of each AOI, including closing dates: AOI #15: ReDIRECT AOI #16: Lab at Home AOI #17: Digital MCMs AOI #18: Host-Directed Therapeutics AOI #19: Healing Lungs AOI #20: DRIVe Forward AOI #21: Vaccines on Demand AOI #22: ReBooT AOI #23: Host-Based Diagnostics _____
BARDA DRIVe EZ-BAA-22-100-SOL-00003
This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/.
BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/. _______ Amendment 001: This amendment to the EZBAA hereby opens the following research areas of interest ("AOI"). Please review the amendment for details of each AOI, including closing dates: AOI #15: ReDIRECT AOI #16: Lab at Home AOI #17: Digital MCMs AOI #18: Host-Directed Therapeutics AOI #19: Healing Lungs AOI #20: DRIVe Forward AOI #21: Vaccines on Demand AOI #22: ReBooT AOI #23: Host-Based Diagnostics _____ 11/8/22 - Please see Amendment 002 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Adding the the following Area of Interest (AOI): AOI #24: REPAIR 2. Clarifying an adminstrative error. _____ 11/14/22 - Please see Amendment 003 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Revising the following Area of Interest (AOI): AOI #19: Healing Lungs _____ 12/15/22 - Please see Amendment 004 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Updating the closing date for the following Area of Interest (AOI): AOI #21: Vaccines on Demand ______ 1/11/23 - Please see Amendment 005 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Pausing the following Area of Interest (AOI) by establishing a new closing date of February 15, 2023 at 12:00PM ET: AOI #15: ReDIRECT ______ 2/1/23 - Please see Amendment 006 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Updating the closing date for the following Area of Interest (AOI): AOI #19: Healing Lungs 2. Updating the closing date for the following Area of Interest (AOI): AOI #17: Digital MCMs 3. Updating the closing date for the following Area of Interest (AOI): AOI #16: Lab at Home 4. Revising the following Area of Interest (AOI): AOI #16: Lab at Home ______ 2/3/23 - Please see Amendment 007 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Updating the closing date for the following Area of Interest (AOI): AOI #24: REPAIR ______ 5/1/23 - Please see Amendment 008 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Adding the following Area of Interest (AOI): AOI #25: FASTx 2. Updating the language in Section III (F) of the Easy Broad Agency Announcement titled “Plus (+) Phase”. ______ 5/18/23 - Please see Amendment 009 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Reopening the following Area of Interest (AOI), which is reopened to support project Next Gen: AOI #21: Vaccines on Demand ______ 5/25/23 - Please see Amendment 010 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Revising the following Area of Interest (AOI): AOI #24: REPAIR 2. Updating the closing date for the following Area of Interest (AOI): AOI #24: REPAIR ______ 6/27/23 - Please see Amendment 011 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Closing the following Area of Interest (AOI): AOI #18: Host-Directed Therapeutics 2. Closing the following Area of Interest (AOI): AOI #23: Host-Based Diagnostics 3. Updating the closing date for the following Area of Interest (AOI): AOI #19: Healing Lungs ______ 9/13/23 - Please see Amendment 012 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Updating the closing date for the following Area of Interest (AOI): AOI #16: Lab at Home 2. Updating the closing date for the following Area of Interest (AOI): AOI #17: Digital MCMs 3. Updating the closing date for the following Area of Interest (AOI): AOI #19: Healing Lungs 4. Revising the following Area of Interest (AOI): AOI #16 Lab at Home 5. Adding the following Area of Interest (AOI): AOI #26: Agnostic Diagnostic _______ 9/14/23 - Please see Amendment 013 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Pausing the following Area of Interest (AOI): AOI #20: DRIVe Forward ________ 9/26/23 - Please see Amendment 014 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Pausing the following Area of Interest (AOI): AOI #21: Vaccines on Demand _________ 10/26/23 - Please see Amendment 015 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Updating the closing date for the following Area of Interest (AOI): AOI #22: ReBoot 2. Updating the closing date for the following Area of Interest (AOI): AOI #25: FASTx 3. Revising the following Area of Interest (AOI): AOI #22: ReBoot 4. Revising the following Area of Interest (AOI): AOI #25: FASTx ___________ 10/30/23 - Please see Amendment 016 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Pausing the following Area of Interest (AOI): AOI #24: REPAIR __________ 11/15/23 - Please see Amendment 017 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Reopening the following Area of Interest (AOI): AOI #20: DRIVe Forward 2. Revising the following Area of Interest (AOI): AOI #20: DRIVe Forward __________ 12/13/23 - Please see Amendment 018 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Updating the closing date for the following Area of Interest (AOI): AOI #16: Lab at Home 2. Revising the following Area of Interest (AOI): AOI #16: Lab at Home 3. Pausing the following Area of Interest (AOI): AOI #17: Digital MCMs 4. Updating the closing date for the following Area of Interest (AOI): AOI #19: Healing Lungs __________ 01/03/24 - Please see Amendment 019 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Reopening the following Area of Interest (AOI): AOI #15: ReDIRECT 2. Revising the following Area of Interest (AOI): AOI #15: ReDIRECT __________ 01/10/24 - Please see Amendment 020 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Pausing the following Area of Interest (AOI): AOI #26: Agnostic Diagnostic 2. Adding a topic to the following Area of Interest (AOI): AOI #20: DRIVe Forward 3. Updating the closing date for the following Area of Interest (AOI): AOI #20: DRIVe Forward _________ 01/18/24 - Please see Amendment 021 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Adding the following Area of Interest (AOI): AOI #27: Stopping Secondary Spread __________ 2/5/24 - Please see Amendment 022 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Pausing the following research Area of Interest (AOI): AOI #27: Stopping Secondary Spread 2. Revise topics for the following research Area of Interest (AOI): AOI #20: DRIVe Forward __________ 02/12/24 - Please see Amendment 023 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Reopening the following Area of Interest (AOI): AOI #26: Agnostic Diagnostic __________ 02/21/24 - Please see Amendment 024 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Updating the closing date for the following Area of Interest (AOI): AOI #22: ReBooT 2. Updating the closing date for the following Area of Interest (AOI): AOI #25: FASTx __________ 03/04/24 - Please see Amendment 025 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Reopening the following Area of Interest (AOI): AOI #24: RePAIR 2. Revising the following Area of Interest (AOI): AOI #24: RePAIR __________ 03/12/24 - Please see Amendment 026 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Updating the closing date for the following Area of Interest (AOI): AOI #16: Lab at Home 2. Updating the closing date for the following Area of Interest (AOI): AOI #19: Healing Lungs _________ 04/22/24 - Please see Amendment 027 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Reopening the following Area of Interest (AOI): AOI #20: DRIVe Forward 2. Removing two topic areas and adding one topic area to the following Area of Interest (AOI): AOI #20: DRIVe Forward _________ 05/01/24 - Please see Amendment 028 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Updating the closing date for the following Area of Interest (AOI): AOI #15: ReDIRECT 2. Updating the closing date for the following Area of Interest (AOI): AOI #26: Agnostic Diagnostic 3. Reopening the following Area of Interest (AOI): AOI #17: Digital MCMs 4. Revising the following Area of Interest (AOI): AOI #17: Digital MCMs __________ 05/09/24 - Please see Amendment 029 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Pausing the following Area of Interest (AOI): AOI #16: Lab at Home 2. Updating the closing date for the following Area of Interest (AOI): AOI #19: Healing Lungs 3. Revising the following Area of Interest (AOI): AOI #19: Healing Lungs 4. Updating the closing date for the following Area of Interest (AOI): AOI #24: RePAIR _________ 09/24/24 - Please see Amendment 030 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Adding the following Area of Interest (AOI): AOI #28: Influenza Vaccine Innovation 2. Pausing the following Area of Interest (AOI): AOI #26: Agnostic Diagnostic ___________ 09/30/24 - Please see Amendment 031 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1. Reopening the following Area of Interest (AOI): AOI #24: RePAIR ___________ 10/10/24 - Please see Amendment 032 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: Update the closing date for the following Area of Interest (AOI): AOI #19: Healing Lungs Pause the following Area of Interest (AOI) on 10/31/24: AOI #17: Digital MCMs ___________ 10/31/24 - Please see Amendment 033 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: Reopen the following Area of Interest (AOI) on 11/1/24: AOI #15: ReDIRECT 2. Remove language requiring a Rough Order of Magnitude (ROM) from the record 11/26/2024 - Please see Amendment 034 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1) Reopen the following Area of Interest (AOI): AOI #22: ReBooT 2) Revise the following Area of Interest (AOI): AOI #22: ReBooT 3) Pause the following Area of Interest (AOI): AOI#24: RePAIR ___________ 1/13/2025 - Please see Amendment 035 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: 1) Reopen the following Area of Interest (AOI) on 1/15/2025: AOI #16: Lab at Home 2) Open the following Area of Interest (AOI): AOI #29: Type to Treat ___________ 2/14/2025 - Please see Amendment 036 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this Amendment, BARDA is: Updating the closing date for the following Area of Interest (AOI): AOI #19: Healing Lung __________ 4/22/2025 - Please see Amendment 037 for Easy Broad Agency Announcement (EZ-BAA) EZ-BAA-22-100-SOL-00003. Under this amendment, BARDA is revising the following Areas of Interest (AOI) to close effective immediately: AOI #19: Healing Lungs AOI #22: ReBooT AOI #29: Type to Treat Additional details can be found in the corresponding Amendment 037.
Browse by Type
Federal Contracting Resources
Learn more about federal contracting opportunities and how to win
Frequently Asked Questions
Find answers to common questions
Articles & Research
In-depth guides and data-driven insights
Glossary
Learn the terminology
Free Tools
Helpful tools for federal contractors